Endocardial endothelial cell hypertrophy takes place during the development of hereditary cardiomyopathy

Danielle Jacques1, Ghassan Bkaily2

  • 1Department of Anatomy and Cell Biology, Faculty of Medicine, Université de Sherbrooke, 3001 12th Avenue North, Sherbrooke, QC, J1H 5N4, Canada. Danielle.Jacques@USherbrooke.ca.

Insights

Endocardial endothelial cells enlarge before cardiac hypertrophy develops in hereditary cardiomyopathy. This finding reveals these cells as a potential new target for treating heart failure.

Area of Science:

  • Cardiovascular Biology
  • Cell Biology
  • Pathology

Background:

  • Endocardial endothelial cells form a barrier between blood and cardiomyocytes.
  • Their role in cardiac pathologies like hypertrophy was previously unknown.
  • Recent work highlighted their importance in excitation-secretion coupling.

Purpose of the Study:

  • To investigate the contribution of endocardial endothelial cells to cardiac hypertrophy.
  • To determine if endocardial endothelial cells undergo hypertrophy in a model of hereditary cardiomyopathy.

Main Methods:

  • Utilized the UM-X7.1 hereditary cardiomyopathic hamster model.
  • Isolated endocardial endothelial cells from cardiomyopathic and normal hamsters.
  • Measured cell volume changes during different disease stages.

Main Results:

  • Endocardial endothelial cells showed increased cell volume during necrosis, preceding cardiac hypertrophy.
  • This enlarged cell volume persisted as cardiac hypertrophy developed.
  • Endocardial endothelial hypertrophy was observed before cardiomyocyte hypertrophy.

Conclusions:

  • Endocardial endothelial hypertrophy precedes cardiac hypertrophy in this model.
  • Released factors from hypertrophied endocardial endothelial cells may drive cardiac hypertrophy.
  • Endocardial endothelial cells represent a novel therapeutic target for hypertrophy and heart failure.

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
575
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
496
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
552
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
459
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
611
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
358